1.新疆医科大学第一附属医院骨科中心关节外科,新疆 乌鲁木齐 830011
2.新疆医科大学药学院, 新疆 乌鲁木齐 830054
穆文博,副主任医师,研究方向:人工关节置换及相关并发症,E-mail: muwenbo8964@163.com。
[ "曹力,主任医师、二级教授、博士研究生导师,英国皇家外科学院 Fellow(F.R.C.S. England)、亚太人工关节协会(APAS)第9任主席(2018-2021年)、美国髋膝关节学会(AAHKS)国际委员会执行委员、国际髋关节协会(International Hip Society)委员,中国医师协会骨科医师分会副会长、中华医学会骨科分会关节外科学组副组长、中国骨科医师协会关节外科委员会副主任委员、中国医师协会骨科医师分会第五届委员会膝关节学组组长、中国医师协会骨科医师分会第五届委员会关节外科学组副组长、中国医师协会毕业后医学教育骨科专业委员会副主任委员。E-mail: xjbone@sina.com" ]
纸质出版日期:2023-03-20,
收稿日期:2022-04-01,
扫 描 看 全 文
穆文博,曹力.保留假体清创术在治疗人工关节置换术后假体周围感染的研究进展[J].中山大学学报(医学科学版),2023,44(02):181-187.
MU Wen-bo,CAO Li.Debridement, Antibiotics and Implant Retention for the Treatment of Periprosthetic Joint Infection After Arthroplasty: A Narrative Review[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):181-187.
穆文博,曹力.保留假体清创术在治疗人工关节置换术后假体周围感染的研究进展[J].中山大学学报(医学科学版),2023,44(02):181-187. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0201.
MU Wen-bo,CAO Li.Debridement, Antibiotics and Implant Retention for the Treatment of Periprosthetic Joint Infection After Arthroplasty: A Narrative Review[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):181-187. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0201.
假体周围感染(PJI)是人工关节置换术后灾难性的并发症,其治疗极具挑战性。目前,PJI治疗手段包括保留假体清创手术,一期翻修手术,二期翻修手术,关节融合术及截肢术等。保留假体清创手术因可避免假体拔除,创伤小,花费少,对医生及患者极具吸引力,本文将对此种治疗方法的手术时机,术中细节及抗生素使用方案等作一综述。
Periprosthetic joint infection (PJI) following joint arthroplasty is devastating and technique-demanding. At present, the surgical treatment for PJI includes debridement, antibiotics, and implant retention (DAIR), single- or two-stage revision, arthrodesis, and amputation. DAIR is appealing to both surgeons and patients as it can avoid unnecessary implants removal, making it less time-consuming and less invasive. In this article, we review the current knowledge in surgical timing, intraoperative details and antibiotics strategy of DAIR.
假体周围感染人工关节保留假体清创术
periprosthetic joint infectionartificial jointimplant retentiondebridement
Lemaignen A, Bernard L, Marmor S, et al. Epidemiology of complex bone and joint infections in France using a national registry: the CRIOAc network[J]. J Infect, 2021, 82(2): 199-206.
Kunutsor SK, Barrett MC, Whitehouse MR, et al. Incidence, temporal trends and potential risk factors for prosthetic joint infection after primary total shoulder and elbow replacement: systematic review and meta-analysis[J]. J Infect, 2020, 80(4): 426-436.
Li C, Ojeda-Thies C, Renz N, et al. The global state of clinical research and trends in periprosthetic joint infection: a bibliometric analysis[J]. Int J Infect Dis, 2020, 96: 696-709.
Löwik CAM, Parvizi J, Jutte PC, et al. Debridement, antibiotics, and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than 4 weeks after index arthroplasty[J]. Clin Infect Dis, 2020, 71(3): 630-636.
Ollivier M, Senneville E, Drancourt M, et al. Potential changes to French recommendations about peri-prosthetic infections based on the international consensus meeting (ICMPJI)[J]. Orthop Traumatol Surg Res, 2014, 100(6): 583-587.
Argenson JN, Arndt M, Babis G, et al. Hip and knee section, treatment, debridement and retention of implant: proceedings of international consensus on orthopedic infections - sciencedirect[J]. J Arthroplasty, 2019, 34(2S): S399-S419.
Lora-Tamayo J, Senneville É, Ribera A, et al. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study[J]. Clin Infect Dis, 2017, 64(12): 1742-1752.
Ottesen CS, Troelsen A, Sandholdt H, et al. Acceptable success rate in patients with periprosthetic knee joint infection treated with debridement, antibiotics, and implant retention[J]. J Arthroplasty, 2019, 34(2): 365-368.
Barberán J, Aguilar L, Carroquino G, et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients[J]. Am J Med, 2006, 119(11): 993.e7-10.
Grammatopoulos G, Kendrick B, McNally M, et al. Outcome following debridement, antibiotics, and implant retention in hip periprosthetic joint infection-an 18-year experience[J]. J Arthroplasty, 2017, 32(7): 2248-2255.
Maillet M, Pavese P, Bruley D, et al. Is prosthesis retention effective for chronic infections in hip arthroplasties? a systematic literature review[J]. Eur J Clin Microbiol Infect Dis, 2015, 34(8): 1495-1502.
Alamanda VK, Springer BD. The prevention of infection: 12 modifiable risk factors[J]. Bone Joint J, 2019, 101-B(1_Supple_A): 3-9.
Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty[J]. Clin Orthop Relat Res, 2013, 471(10): 3112-3119.
Boyer B, Cazorla C. Methods and probability of success after early revision of prosthetic joint infections with debridement, antibiotics and implant retention[J]. Orthop Traumatol Surg Res, 2021, 107(1S): 102774-102781.
Lass R, Giurea A, Kubista B, et al. Bacterial adherence to different components of total hip prosthesis in patients with prosthetic joint infection[J]. Int Orthop, 2014, 38(8): 1597-1602.
Tsang SJ, Ting J, Simpson AHRW, et al. Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies[J]. Bone Joint J, 2017, 99-B(11): 1458-1466.
Grammatopoulos G, Bolduc ME, Atkins BL, et al. Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study[J]. Bone Joint J, 2017, 99-B(5): 614-622.
Deirmengian C, Greenbaum J, Lotke PA, et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty[J]. J Arthroplasty, 2003, 18(7 Suppl 1): 22-26.
Choi HR, von Knoch F, Zurakowski D, et al. Can implant retention be recommended for treatment of infected TKA?[J]. Clin Orthop Relat Res, 2011, 469(4): 961-969.
Koh IJ, Han SB, In Y, et al. Open debridement and prosthesis retention is a viable treatment option for acute periprosthetic joint infection after total knee arthroplasty[J]. Arch Orthop Trauma Surg, 2015, 135(6): 847-855.
Glynn AA, O'Donnell ST, Molony DC, et al. Hydrogen peroxide induced repression of icaADBC transcription and biofilm development in Staphylococcus epidermidis[J]. J Orthop Res, 2009, 27(5): 627-630.
George DA, Konan S, Haddad FS. Single-stage hip and knee exchange for periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(12): 2264-2270.
Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections?[J]. Clin Orthop Relat Res, 2015, 473(1): 8-14.
Riesgo AM, Park BK, Herrero CP, et al. Vancomycin povidone-iodine protocol improves survivorship of periprosthetic joint infection treated with irrigation and debridement[J]. J Arthroplasty, 2018, 33(3): 847-850.
Zubko EI, Zubko MK. Co-operative inhibitory effects of hydrogen peroxide and iodine against bacterial and yeast species[J]. BMC Res Notes, 2013, 6: 272.
Niki Y, Matsumoto H, Otani T, et al. How much sterile saline should be used for efficient lavage during total knee arthroplasty? effects of pulse lavage irrigation on removal of bone and cement debris[J]. J Arthroplasty, 2007, 22(1): 95-99.
Tan TL, Kheir MM, Shohat N, et al. Culture-negative periprosthetic joint infection: an update on what to expect[J]. JB JS Open Access, 2018, 3(3): e0060- e0065.
Tirumala V, Smith E, Box H, et al. Outcome of debridement, antibiotics, and implant retention with modular component exchange in acute culture-negative periprosthetic joint infections[J]. J Arthroplasty, 2021, 36(3): 1087-1093.
Yoon HK, Cho SH, Lee DY, et al. A review of the literature on culture-negative periprosthetic joint infection: epidemiology, diagnosis and treatment[J]. Knee Surg Relat Res, 2017, 29(3): 155-164.
Pastel DA. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination[J]. Clin Pharm, 1986, 5(9): 719-736.
Ji B, Li G, Zhang X, et al. Effective treatment of single-stage revision using intra-articular antibiotic infusion for culture-negative prosthetic joint infection[J]. Bone Joint J, 2020, 102-B(3): 336-344.
Mu W, Xu B, Guo W, et al. Outcome of irrigation and debridement with topical antibiotics delivery for the management of periprosthetic joint infection occurring within 3 months since the primary total joint arthroplasty[J]. J Arthroplasty, 2021, 36(5):1765-1771.
Fink B, Schuster P, Schwenninger C, et al. A stan‐dardized regimen for the treatment of acute postopera‐tive infections and acute hematogenous infections asso‐ciated with hip and knee arthroplasties[J]. J Arthro‐plasty, 2017, 32(4): 1255-1261.
Manning L, Metcalf S, Dymock M, et al. Short-versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint[J]. Int J Antimicrob Agents, 2022, 60(1): 106598-106607.
Shah NB, Hersh BL, Kreger A, et al. Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection[J]. Clin Infect Dis, 2020, 70(4): 559-565.
Heim CE, Bosch ME, Yamada KJ, et al. Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection[J]. Nat Microbiol, 2020, 5(10): 1271-1284.
Schwarzer S, James GA, Goeres D, et al. The efficacy of topical agents used in wounds for managing chronic biofilm infections: a systematic review[J]. J Infect, 2020, 80(3): 261-270.
Geurts JA, Janssen DM, Kessels AG, et al. Good results in postoperative and hematogenous deep infections of 89 stable total hip and knee replacements with retention of prosthesis and local antibiotics[J]. Acta Orthop, 2013, 84(6): 509-516.
Levack AE, Turajane K, Yang X, et al. Thermal stability and in vitro elution kinetics of alternative antibiotics in polymethylmethacrylate (PMMA) bone cement[J]. J Bone Joint Surg Am, 2021, 103(18): 1694-1704.
Hamad C, Chowdhry M, Sindeldecker D, et al. Adaptive antimicrobial resistance, a description of microbial variants, and their relevance to periprosthetic joint infection[J]. Bone Joint J, 2022, 104-B(5): 575-580.
Ghnaimat M, Alyamani A, Obeidat M, et al. Is DAIR still an effective way to eradicate acute prosthetic joint infections? our experience in the jordanian royal medical services[J]. Med Arch, 2021, 75(6): 451-455.
Roy ME, Peppers MP, Whiteside LA, et al. Vancomycin concentration in synovial fluid: direct injection into the knee vs. intravenous infusion[J]. J Arthroplasty, 2014, 29(3): 564-568.
Tsumura H, Ikeda S, Ono T, et al. Synovectomy, debridement, and continuous irrigation for infected total knee arthroplasty[J]. Int Orthop, 2005, 29(2): 113-116.
Fukagawa S, Matsuda S, Miura H, et al. High-dose antibiotic infusion for infected knee prosthesis without implant removal[J]. J Orthop Sci, 2010, 15(4): 470-476.
Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group[J]. JAMA, 1998, 279(19): 1537-1541.
Fiaux E, Titecat M, Robineau O, et al. Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations[J]. BMC Infect Dis, 2016, 16(1): 568-576.
Puhto AP, Puhto T, Niinimäki T, et al. Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention[J]. Int Orthop, 2015, 39(9): 1785-1791.
Senneville E, Joulie D, Legout L, et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus[J]. Clin Infect Dis, 2011, 53(4): 334-340.
吴小宇, 叶勇裕, 潘柏祺, 等. 凝血相关指标在关节假体周围感染中的诊断价值[J]. 中山大学学报(医学科学版), 2023, 44(2): 188-197.
Wu XY, Ye YY, Pan BQ, et al. Coagulation factors for diagnosis of periprosthetic joint infection[J]. J Sun Yat-sen Univ, 2023, 44(2): 188-197.
0
浏览量
2
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构